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Summary
Background: Serum inhibition of allergen-specific IgE has been associated with competing IgG4 
and non-specific polyclonal IgE. In allergen immunotherapy, beneficial responses have been 
associated with high IgG4/IgE ratios. Helminths potentiate antibody class switching to IgG4 and 
stimulate polyclonal IgE synthesis; therefore, we hypothesised a role for helminth-associated IgG4 
and total IgE in protection against atopic sensitisation and clinical allergy (asthma) in tropical low-
income countries.
Methods: Among community residents of Ugandan rural Schistosoma mansoni (Sm)-endemic 
islands and a mainland urban setting with lower helminth exposure, and among urban asthmatic 
schoolchildren and non-asthmatic controls, we measured total, Schistosoma adult worm antigen 
(SWA)-specific, Schistosoma egg antigen (SEA)-specific and allergen (house dust mite [HDM] 
and German cockroach)-specific IgE and IgG4 by ImmunoCAP® and/or ELISA. We assessed 
associations between these antibody profiles and current Sm infection, the rural-urban 
environment, HDM and cockroach skin prick test (SPT) reactivity, and asthma.
Results: Total IgE, total IgG4 and SWA-, SEA- and allergen-specific IgE and IgG4 levels were 
significantly higher in the rural, compared to the urban setting. In both community settings, both 
Sm infection and SPT reactivity were positively associated with allergen-specific and total IgE 
responses. SPT reactivity was inversely associated with Schistosoma-specific IgG4, allergen-
specific IgG4/IgE ratios and total IgE/allergen-specific IgE ratios. Asthmatic schoolchildren, 
compared to non-asthmatic controls, had significantly higher levels of total and allergen-specific 
IgE, but lower ratios of allergen-specific IgG4/IgE and total IgE/allergen-specific IgE. 
Conclusions and clinical relevance: Our immuno-epidemiological data support the hypothesis 
that the IgG4–IgE balance and the total IgE–allergen-specific IgE balance are more important than 
absolute total, helminth- or allergen-specific antibody levels in inhibition of allergies in the 
tropics. 
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Introduction
Several immuno-epidemiological studies have shown that helminth infections are associated with 
protection against allergy-related conditions,1-9 and highlighted the potential role of helminths in 
rural-urban differences in prevalence of allergy-related diseases in the tropics.10,11 We have 
previously shown that maternal hookworm infection modifies risk factors for childhood eczema, 
implying that early-life exposure to helminths may also establish protection against allergy-related 
diseases.12 Experimental human and animal studies have demonstrated that the mechanisms 
through which helminths may down-modulate allergic responses are extensive,13,14 covering 
almost the entire range of the allergy-related immunological pathway. Antibody-mediated immune 
mechanisms of protection are less understood compared to cell-mediated mechanisms: current 
theories involve helminth-induced immunoglobulin (Ig) G4 and polyclonally-stimulated IgE. 
By inducing high levels of interleukin (IL)-10, helminths can promote immunoglobulin class 
switching to IgG4. Moreover, chronic helminth infection is associated with elevated serum IgG4 
levels,15 and serum inhibition of helminth-specific IgE has been associated with competing IgG4 
in a Schistosoma mansoni (Sm)-endemic setting.16 Several human studies have suggested that 
helminth-induced IgG4 is important in protection against allergy: among school-age children in 
rural Ecuador, Ascaris-specific IgG4 was inversely associated with allergen skin prick test (SPT) 
reactivity;2 in a Sm-endemic Ugandan rural setting, we observed an inverse association between 
house dust mite‐specific IgG4/IgE ratios and reported recent wheeze.17
Studies conducted four decades ago18,19 provided initial evidence that parasitic helminths mediate 
production of high levels of IgE that is not specific to the parasite, or to inhalant allergens. Non-
specific polyclonally-stimulated IgE has been proposed to inhibit allergic responses by competing 
with allergen-specific IgE to saturate IgE receptors,20 reducing the chances that an allergen will 
result in cross-linking of FcεRI-bound IgE and hence effector cell degranulation.14,21 However, 
there is little evidence for polyclonal IgE-mediated protection against allergic inflammation, and 
high IgE titres have previously been linked to increased expression of IgE receptors on human 
basophils,22 signifying potential for polyclonally-stimulated IgE in increased effector cell 
degranulation. Therefore, the question of whether polyclonal IgE mitigates allergic responses 
remains unresolved.
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better understand population-level interactions between allergy-related disease and helminth- and 
allergen-associated IgG4 and polyclonal IgE profiles. This will contribute to bridging the gap 
between understanding basic antibody mechanisms and clinical applications. We used the 
opportunity presented by studies designed to assess the epidemiology of allergy-related disease in 
1) Sm-endemic Ugandan rural fishing villages,17,23-25 2) proximate urban communities with lower 
helminth exposure,11 and 3) urban asthmatic schoolchildren and non-asthmatic controls.26,27 
Samples collected enabled us to measure total IgE (as a proxy for polyclonally-stimulated IgE), 
total IgG4 and Sm- and allergen-specific IgE and IgG4 profiles, and to analyse their associations 
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Methods
Study design and population
The current investigation was conducted using samples from participants of cross-sectional 
community surveys in rural24 and urban11 Uganda, and from a case-control study investigating 
asthma risk factors among 5-17-year-old schoolchildren in urban Uganda.26
The rural survey was the three-year outcome survey (September 2015 – August 2016) of the Lake 
Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA; 
ISRCTN47196031).23-25 The LaVIISWA trial was conducted in 26 Sm-endemic rural fishing 
villages of Koome islands, Lake Victoria. It was an open cluster-randomised trial of community-
wide standard versus intensive anthelminthic mass drug administration (MDA). 
The urban survey (September 2016 – September 2017) was designed to collect data for 
comparison with the rural survey.11 It was conducted in Entebbe municipality, a lower helminth 
exposure, urban setting situated on the northern shores of Lake Victoria (approximately 35km 
from Koome islands and 40km from Uganda’s capital, Kampala).11 Procedures in the urban survey 
mirrored those in the rural survey; however, urban survey participants were not randomised to 
standard versus intensive MDA.
The asthma case-control study (May 2015 – July 2017)26 enrolled children with doctor-diagnosed 
asthma (“cases”) and non-asthmatic controls from primary and secondary schools in Entebbe 
municipality and Katabi sub-county in Wakiso, Uganda. The International Study on Allergy and 
Asthma in Children (ISAAC) questionnaire28 was used for screening, to identify participants who 
reported wheezing in the previous 12 months. These children then underwent a comprehensive 
clinical evaluation of medical and treatment history, and examination for asthma signs and 
symptoms by study clinicians in order to make an asthma diagnosis. Lung function tests and 
Asthma Control Tests26,27 were conducted to assess asthma control. As reported elsewhere,27 only 
three cases had abnormal lung function tests, 85% had well- or partly-controlled asthma and 15% 
had poorly-controlled asthma. All cases were seen at one time-point, started on recommended 
treatment and referred for further management, therefore, asthma severity or response to treatment 
could not be assessed.27  Non-asthmatic controls were children in the same class as cases, with no 
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(StataCorp, College Station, TX, USA) to obtain a control/case ratio of 2:1. 
Parasitological examinations
In all studies, we used the stool Kato-Katz (KK) technique29 for diagnosis of Sm, hookworm 
(Necator americanus), Ascaris lumbricoides and Trichuris trichiura infections. For each 
participant, one stool sample (prepared on two slides) was examined under a microscope by two 
laboratory technologists blinded to each other’s result. In the rural and urban surveys, stool was 
further suspended in 70% ethanol, stored at -80oC, and later examined for Sm, Strongyloides 
stercoralis and hookworm infections using multiplex real-time PCR.30,31 Infection with 
Schistosoma haematobium has not been documented in our study areas.32 Plasma samples were 
assessed for Schistosoma adult worm (SWA)- and egg (SEA)- antigen-specific IgE and IgG4 by 
ELISA (details in supplementary information).
Assessment of allergy-related outcomes
Wheezing in the previous 12 months was also assessed in the rural and urban surveys using 
interviewer-administered standardised paper and video ISAAC questionnaires. Skin prick test 
(SPT) reactivity to crude extracts from Dermatophagoides mix (D. pteronyssinus and D. farinae), 
Blomia tropicalis and Blattella germanica (ALK-Abelló; supplied by Laboratory Specialities [Pty] 
Ltd., SA) was assessed using standard methods.33 These allergens are common in the study 
settings.34 We used an in-house ELISA to quantify crude house dust mite (D. pteronyssinus, 
HDM) and German cockroach (B. germanica) extract-specific plasma IgG4 and total IgG4. Total 
IgE and allergen extract-specific IgE were measured using the ImmunoCAP IgE test (Thermo 
Fisher Scientific, Uppsala, Sweden).35 Allergen extract-specific IgE was additionally measured 
using an in-house ELISA, to facilitate determination of IgG4/IgE ratios, since, for logistical 
reasons, we could not measure allergen-specific IgG4 by ImmunoCAP®. The in-house assays are 
described in this article’s supplementary information.
Statistical methods
Statistical analyses were conducted using Stata 15.0 (StataCorp, College Station, TX, USA). 
Graphs were drawn using GraphPad Prism (version 8.2.1, Fay Avenue, CA, USA). We accounted 
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commands were used to allow for the non‐self‐weighting clustering by village in the rural survey 
and for clustering by sub‐ward in the urban survey.11 Initial analyses in the rural survey assessed 
the impact of intensive versus standard MDA on IgE and IgG4 profiles. For this, we used a 
cluster-level approach36 (previously described in other analyses for this study24) that involved 
comparing cluster-specific means of antibody concentrations between trial arms, with 95% 
confidence intervals and p-values calculated using the t-distribution. For all subsequent analyses, 
standard and intensive trial arm participants in the rural survey were grouped together. 
Next, participant characteristics were tabulated and compared between urban and rural settings 
and separately, between asthma cases and controls, using logistic and linear regression for 
categorical and continuous variables, respectively. 
Independently for each of the three studies, we conducted crude and age- and sex-adjusted cross-
sectional analyses to investigate the direction and the strength of association between antibody 
concentrations or ratios (total, Schistosoma-specific and allergen-specific IgE and IgG4 
concentrations; allergen-specific IgG4/IgE, total IgE/allergen-specific IgE, total IgG4/total IgE 
ratios) and Sm infection or SPT reactivity. In the asthma case-control study, we additionally 
investigated associations between asthma and antibody concentrations and ratios. Rural-urban 
comparisons of antibody profiles were conducted using data from the rural and urban surveys. 
Most raw antibody concentrations and ratios were skewed, so for all analyses, linear regression 
models of log-transformed data were used. ImmunoCAP® allergen-specific IgE concentrations 
were log10 (+0.001)-transformed, while all other antibody data were log10 (+1)-transformed. The 
results were then back-transformed to obtain geometric mean ratios (GMRs) and 95% confidence 
intervals (CI).
Ethics statement
Our studies were approved by research ethics committees of Uganda Virus Research Institute 
(reference numbers: GC/127/12/05/03, GC/127/16/02/547 and GC/127/14/09/481) and London 
School of Hygiene and Tropical Medicine (reference numbers: 6187 and 10709), and the Uganda 
National Council for Science and Technology (reference numbers: HS1183, HS2036 and 
HS1707). We obtained written informed consent from all participants and/or their legal guardians. 
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Results
Characteristics of study participants
Flowcharts of the three studies are shown in Figure 1. Plasma samples were available for 2961, 
1356 and 1685 participants of the rural survey, urban survey and asthma case-control study, 
respectively. Antibody measurements were conducted in a subset of randomly selected samples 
per study: 791, 1320 and 406 plasma samples from the rural survey, urban survey and asthma 
case-control study, respectively, were included in assessment of at least one of total, Schistosoma- 
or allergen-specific IgE or IgG4. There was no effect of intensive versus standard anthelminthic 
MDA on antibody profiles (supplementary Table S1), hence data from both trial arms in the rural 
survey were combined for all subsequent analyses.
Table 1 shows characteristics of participants for whom we obtained data on total, Schistosoma- or 
allergen-specific IgE or IgG4. Participant characteristics were compared between the rural and 
urban surveys, and between asthma cases and controls. We have previously reported related 
comparisons in these studies, albeit in somewhat different subsets of participants.37 Rural, 
compared to urban participants, were more likely to be older (p=0.001) and male (p=0.003). 
Prevalence of SPT reactivity to Dermatophagoides mix and B. tropicalis was higher among urban 
participants (p=0.001). However, rural participants had higher median total IgE levels (p<0.001), 
and higher prevalence of IgE sensitisation to crude German cockroach (ImmunoCAP® 
concentration ≥0.35 kU/L) [p=0.001], ELISA-detectable cockroach-specific IgE (≥312.5 ng/ml) 
[p=0.001], and infection with Sm (p<0.001) and at least one nematode (p<0.001). Reported 
wheeze was rare in both settings. 
Compared to non-asthmatic controls, asthma cases were on average older, and more likely to be 
SPT positive, and to have higher total and allergen-specific IgE levels. Helminth infection 
prevalence was low in the asthma case-control study, and comparable between cases and controls 
(Table 1).
Associations between antibody (IgE and IgG4) concentrations and current S. mansoni infection 
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In the rural survey (Table 2), Sm infection was positively associated with total and SWA- and 
SEA-specific IgE and IgG4 (p<0.001), and cockroach-specific IgG4 concentrations (p=0.002). 
Cockroach SPT reactivity was positively associated with ImmunoCAP®-determined cockroach-
specific IgE (adjusted GMR [95% CI]: 8.30 [5.16, 13.35], p<0.001) and total IgE concentrations 
(1.70 [1.21, 2.39], p=0.003). Dermatophagoides (hereinafter HDM) SPT reactivity was positively 
associated with HDM-specific IgE (ImmunoCAP®: 30.7 [17.43, 54.25], p<0.001; ELISA: 8.47 
[3.52, 20.40], p<0.001), but inversely associated with SWA-specific IgG4 (0.48 [0.27, 0.86], 
p=0.016).
In the urban survey (Table 3), Sm infection was positively associated with total and SWA- and 
SEA-specific IgE and IgG4 (p<0.001), and ELISA-determined HDM-specific IgE (p=0.037), 
cockroach-specific IgE (p=0.040) and cockroach-specific IgG4 concentrations (p=0.005). 
Cockroach SPT reactivity was positively associated with cockroach-specific IgE (ImmunoCAP®: 
13.49 [7.19, 25.32], p<0.001; ELISA: 4.64 [2.00, 10.78], p=0.001), cockroach-specific IgG4 
(3.45 [1.76, 6.77], p=0.001), and total IgE concentrations (4.19 [2.80, 6.28], p<0.001). Despite a 
positive association with SEA-specific IgE (1.13 [1.03, 1.23], p=0.012), cockroach SPT reactivity 
was inversely associated with SEA-specific IgG4 (0.48 [0.27, 0.86], p=0.016). HDM SPT 
reactivity was positively associated with HDM-specific IgE (ImmunoCAP®: 47.48 [24.1, 93.68], 
p<0.001; ELISA: 24.69 [12.9, 47.39], p<0.001), HDM-specific IgG4 (2.10 [1.53, 2.87], p<0.001) 
and total IgE concentrations (2.46 [1.65, 3.67], p<0.001).
Akin to observations in the rural and urban surveys, cockroach and HDM SPT reactivity were 
generally positively associated with total and with cockroach- and HDM-specific IgE 
concentrations respectively among both asthma cases and non-asthmatic controls (supplementary 
Table S2).
Associations between antibody ratios and current S. mansoni infection and skin prick test 
reactivity
Schistosoma mansoni infection was positively associated with total IgE/cockroach-specific IgE 
ratios in both community surveys (rural: 1.76 [1.31, 2.34], p<0.001; urban: 2.39 [1.56, 3.66], 
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p=0.002)  [Figure 2A]. There were no significant associations between Sm infection and antibody 
ratios in the asthma case-control study.
In all three studies, cockroach SPT reactivity was inversely associated with total IgE/cockroach-
specific IgE ratios (rural: 0.23 [0.16, 0.32], p<0.001; urban: 0.31 [0.15, 0.64], p=0.003; asthma 
study: 0.23 [0.17, 0.33], p<0.001) [Figure 2B]. Cockroach SPT reactivity was also inversely 
associated with total IgG4/total IgE ratios in the urban survey (0.41 [0.24, 0.70], p=0.002) and in 
the asthma case-control study (0.42 [0.25, 0.73], p=0.002), and with cockroach-specific IgG4/IgE 
ratios in the asthma case-control study (0.42 [0.19, 0.94], p=0.034) [Figure 2B]. 
In all three studies, HDM SPT reactivity was inversely associated with total IgE/HDM-specific 
IgE ratios (rural: 0.05 [0.03, 0.08], p<0.001; urban: 0.05 [0.03, 0.10], p<0.001; asthma study: 
0.03 [0.02, 0.04], p<0.001), and HDM-specific IgG4/IgE ratios (rural: 0.32 [0.19, 0.55], p<0.001; 
urban: 0.17 [0.11, 0.28], p<0.001; asthma study: 0.04 [0.02, 0.09], p<0.001) [Figure 2C]. HDM 
SPT reactivity was also inversely associated with total IgG4/total IgE ratios in the asthma case-
control study (0.34 [0.22, 0.52], p<0.001) [Figure 2C].
Assessment of associations between antibody ratios and skin prick test reactivity, independently 
among asthma cases and non-asthmatic controls, showed observations akin to the above: 
cockroach and HDM SPT reactivity were inversely associated with allergen-specific IgG4/IgE 
ratios, total IgE/allergen-specific IgE ratios and total IgG4/total IgE ratios (supplementary Table 
S3).
Rural-urban comparison of plasma IgE and IgG4 levels
Urban, compared to rural survey participants had lower geometric mean concentrations of SEA- 
and SWA-specific IgE, IgG and IgG4 (p<0.001), cockroach-specific IgE (ImmunoCAP®: 
p=0.041; ELISA: p=0.017) and IgG4 (p=0.038), total IgE (p<0.001), total IgG4 (p=0.011), total 
IgE/cockroach-specific IgE ratios (p<0.001) and total IgE/HDM-specific IgE ratios (p<0.001) 
[Table 4]. However, HDM-specific IgE (ImmunoCAP®, p=0.038) and IgG4 (p=0.001), and 
HDM-specific IgG4/IgE ratios (p=0.011), were higher in the urban survey.
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Asthma was positively associated with total IgE (1.53 [1.13, 2.05], p=0.005), cockroach-specific 
IgE (ELISA: 2.65 [1.31, 5.34], p=0.007; ImmunoCAP®: 2.03 [1.39, 2.97], p<0.001), and HDM-
specific IgE (ELISA: 4.99 [2.33, 10.72], p<0.001; ImmunoCAP®: 4.79 [2.72, 8.44], p<0.001) 
[Figure 3A]. Conversely, there were inverse associations between asthma and total IgE/HDM-
specific IgE ratios (0.33 [0.21, 0.50], p<0.001), total IgE/cockroach-specific IgE ratios (0.75 
[0.57, 0.99], p=0.047) and HDM-specific IgG4/IgE ratios (0.24 [0.12, 0.48], p<0.001) [Figure 
3B]. 
Asthma is a syndrome of different phenotypes,38 and is sometimes broadly grouped into “allergic” 
and “non-allergic” phenotypes based on atopic sensitisation. In our case-control study, “allergic” 
(SPT positive) asthma cases had lower HDM-specific IgG4/IgE, total IgG4/total IgE and total 
IgE/allergen-specific IgE ratios, compared to “non-allergic” (SPT negative) asthma cases 
(supplementary Table S3 and Figure S1A and S1B). Furthermore, HDM SPT positive asthma 
cases had lower HDM-specific IgG4/IgE, total IgG4/total IgE and total IgE/HDM-specific IgE 
ratios, compared to both SPT negative and SPT positive controls (supplementary Table S3 and 
Figure S1A). The same trend was observed for comparisons between cockroach SPT positive 
asthma cases and both SPT negative and SPT positive controls, albeit without statistical 
significance (Figure S1B). Interestingly, HDM and cockroach SPT negative asthma cases had 
lower geometric means of allergen-specific IgG4/IgE and total IgE/allergen-specific IgE ratios 
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Discussion
We assessed total, Schistosoma- and allergen-specific IgE and IgG4 concentrations among 
participants of three large population-based studies in Uganda and found strong inverse 
associations between allergen SPT reactivity and Schistosoma-specific IgG4, allergen-specific 
IgG4/IgE ratios and total IgE/allergen-specific IgE ratios. Importantly, doctor-diagnosed asthma 
cases also had significantly lower allergen-specific IgG4/IgE ratios and total IgE/allergen-specific 
IgE ratios compared to non-asthmatic controls. Sm infection and the rural (versus urban) 
environment were positively associated with total, Schistosoma- and allergen-specific IgE and 
IgG4, and with allergen-specific IgG4/IgE ratios and total IgE/allergen-specific IgE ratios.
Host responses to helminths exhibit significant similarities with responses to common allergens, 
owing to related molecular targets.39-42 This probably explains observed positive associations 
between Sm infection and allergen-specific IgG4 and IgE among participants of our rural and 
urban community surveys. Strong positive associations between Sm infection and total IgE are 
consistent with observations of helminth-induced polyclonal stimulation of non-specific IgE.18 It 
is plausible that helminths potentiate synthesis of this seemingly superfluous IgE primarily as an 
immune evasion mechanism: disproportionately elevated levels of non-helminth-specific IgE 
saturate available IgE receptors (FcεRIs) on effector cells, inhibiting specific mediator release.43 
This is expected to have benefits for the helminth, but also inadvertent bystander effects on 
allergic responses, as allergens will be outcompeted and less likely to cross-link FcεRI-bound 
IgE.14,20,21 
Mitre et al.44 initially found that a high total IgE/allergen-specific IgE ratio did not inhibit basophil 
degranulation, but further experiments suggested that inhibition could occur at ratios exceeding 
500:1. In the current analysis, we show that total IgE/allergen-specific IgE ratios were strongly 
inversely associated with allergen SPT reactivity (irrespective of study setting), and with asthma, 
providing strong support for the above hypotheses. Moreover, geometric means of total 
IgE/allergen-specific IgE ratios exceeded 700 among non-asthmatic controls in the case-control 
study, and 1000 among our Sm infected and SPT negative participants irrespective of study setting 
– in excess of Mitre’s threshold for inhibition.
Our observations of inverse associations between allergen-specific IgG4/IgE ratios and SPT 
reactivity and asthma strengthen the argument that the IgG4–IgE balance is also important in 
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significantly lower among HDM SPT reactive rural survey participants and cockroach SPT 
reactive urban survey participants, respectively. Although IgG4 has been implicated in IgG4-
related disease,45 it appears to have a more prominent role in immune regulation16 and tolerance.46 
Besides, IgG4 does not activate the complement system or lead to formation of immune 
complexes, and is not associated with mast cell or basophil degranulation.47 Its major mode of 
action against allergic inflammation seems to be blockage of allergen recognition by IgE, because 
both antibodies have similar antigenic specificity.16,48,49 Furthermore, concurrent binding of the 
FcεRI and the inhibitory IgG receptor (FcγRIIB) by IgE and IgG4, respectively, may result in a 
FcγRIIB-dependent inhibition of IgE-mediated effector cell activation.49-51 It is worth noting that 
other IgG classes have also been associated with IgE blocking; however, IgG4 seems to play the 
bigger role.52
There is a counter-argument that IgG4 might not have a direct mechanistic role in protection 
against allergy-related outcomes. Instead, the inverse association between IgG4 levels and IgE 
effector function may represent an ‘epiphenomenon’, merely reflective of parallel phenomena, 
such as abundance of IL-10 (and/or TGF-β)-producing T regulatory and B regulatory cells.53 
However, the latter hypothesis remains to be confirmed by experimental studies.
We measured allergen extract-specific IgE using the standard ImmunoCAP® test, and later, using 
an in-house ELISA assay. The latter technique was used to facilitate determination of IgG4/IgE 
ratios, since, for logistical reasons, we could not measure allergen-specific IgG4 by 
ImmunoCAP®. However, patterns of associations with ImmunoCAP®- and ELISA-determined 
IgE were comparable (except for cockroach-specific IgE in a few instances). We did not formally 
adjust for multiple statistical testing. However, our interpretations rely on patterns and magnitude 
of associations, and consistency and biological credibility of our findings based on other published 
works. It is noteworthy that our studies were cross-sectional; therefore, it was not possible to 
demonstrate causal relationships between antibody profiles and Sm infection, the rural-urban 
environment, allergic sensitisation and asthma.
In conclusion, we underline the potential role of the total IgE – allergen-specific IgE balance and 
the IgG4 – IgE balance in mitigation of allergic responses, providing correlative evidence from 
three cross-sectional population-based studies. These results build upon previous findings that 
apportion high IgG4/IgE ratios an important role in allergen-specific immunotherapy.46 Further 
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polyclonally-stimulated IgE) in mitigation of allergy-related disease; however, they are hindered 
by the lack of IgG4 in mice. Therefore, future work should focus on in vitro experiments using 
human samples. For example, a microarray screening platform could be utilised to identify 
helminth antigens that provoke robust serum IgG4 and little or no IgE response. Such antigens 
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TABLES
Table 1. Characteristics of study participants
Characteristics Rural survey Urban survey
Case-control study on asthma in 
schoolchildren n/N (%)
n/N (%)* n/N (%)* p¶ Controls Asthma cases p
Socio-demographic 
Age in years, median (IQR) 28 (21, 36) 21 (9, 32) 0.001 10 (8, 13) 11 (10, 14) 0.023
Male sex 382/788 (46.4) 510/1315 (38.8) 0.003 93/200 (46.7) 92/200 (46.0) 0.847
Allergy-related outcomes
Skin prick test reactivity
Dermatophagoides mix 89/788 (10.2) 223/1270 (17.6) 0.001 49/200 (24.5) 91/198 (45.9) <0.001
Blomia tropicalis 55/788 (6.9) 180/1270 (14.2) 0.001 46/200 (23.0) 90/198 (45.4) <0.001
Blattella germanica 100/787 (14.1) 182/1273 (14.3) 0.913 33/200 (16.5) 48/198 (24.2) 0.056
asIgE sensitisation (≥0.35 
kU/L, ImmunoCAP)
D. pteronyssinus 264/780 (33.2) 104/345 (30.1) 0.421 72/200 (36.0) 117/200 (58.5) <0.001
Blattella germanica 393/780 (49.8) 118/345 (34.2) <0.001 90/200 (45.0) 112/199 (56.3) 0.025
Detectable asIgE (≥312.5 
ng/ml, ELISA)‡
D. pteronyssinus 312/766 (39.9) 496/1313 (37.8) 0.452 71/190 (37.4) 105/191 (54.0) 0.001
Blattella germanica 349/766 (45.4) 492/1313 (37.5) 0.001 69/190 (36.3) 96/191 (50.3) 0.006
Total IgE (kU/L, 
ImmunoCAP), median 
(IQR)
672 (250, 1942) 159 (57, 523) <0.001 279 (98, 648) 487 (115, 1248) 0.018
Wheeze in last 12 months 25/781 (2.8) 24/1157 (2.1) 0.377 0/200 (0.0) 200/200 (100.0)
Helminth infections
S. mansoni (KK) 188/686 (29.4) 79/1079 (7.3) <0.001 8/196 (4.1) 12/184 (6.5) 0.291
S. mansoni intensity (KK)
Uninfected 498/686 (70.6) 1000/1079 (92.7) 188/196 (95.9) 172/184 (93.5)
Low 95/686 (14.7) 38/1079 (3.5) 4/196 (2.0) 7/184 (3.8)
Moderate 53/686 (8.9) 27/1079 (2.5) 3/196 (1.5) 3/184 (1.6)
Heavy 40/686 (5.8) 14/1079 (1.3) <0.001 1/196 (0.5) 2/184 (1.1) 0.272
S. mansoni (PCR)§ 313/686 (47.4) 190/1073 (17.7) <0.001
Any nematode# 160/688 (21.2) 110/1086 (10.1) <0.001 14/202 (6.9) 22/201 (10.9) 0.161
This article is protected by copyright. All rights reserved
Table shows characteristics for individuals with data on total, Schistosoma- or allergen-specific IgE and IgG4. P-values are 
shown for differences in characteristics between rural and urban survey participants and between asthmatic schoolchildren 
and non-asthmatic controls.
*Percentages were adjusted for survey design. Percentages / medians that were significantly higher in one group compared to 
the other (p≤0.05) are highlighted in bold. Adjusting for age and sex had little impact on these differences.
¶P values obtained from survey design-based logistic or linear regression.
‡Lower detection limit was 15.625 ng/ml. 20-fold diluted plasma samples were used; hence, the lower detection limit in 
undiluted plasma was calculated as 312.5 ng/ml.
§Information not collected in the asthma case-control study.
# Rural survey and urban survey: infection with any of A. lumbricoides (KK), N. americanus (PCR), T. trichiura (KK), or S. 
stercoralis (PCR). Asthma case-control study: infection with any of A. lumbricoides (KK), N. americanus (KK) or T. 
trichiura (KK). Data on S. stercoralis infection not collected in the asthma case-control study.
asIgE: allergen-specific IgE; KK: Kato-Katz; PCR: Polymerase Chain Reaction; CCA: Circulating Cathodic Antigen; IQR: 
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Table 2. Rural survey: associations between antibody (IgE and IgG4) concentrations and current 
S. mansoni infection and skin prick test reactivity 
Antigen Antibody Geometric mean aGMR (95% CI) ‡# p value
Sm- * Sm+
IgE§ 3806 5263 1.33 (1.19, 1.49) <0.001
SWA
IgG4§ 43417 147139 2.98 (1.87, 4.74) <0.001
IgE§ 3645 5206 1.43 (1.25, 1.64) <0.001
SEA
IgG4§ 31284 256465 6.13 (2.84, 13.24) <0.001
IgE¶ 0.13 0.18 1.34 (0.85, 2.12) 0.193
IgE§ 24.25 27.16 1.29 (0.78, 2.11) 0.305House dust mite
IgG4§ 11.31 14.26 1.35 (0.98, 1.85) 0.065
IgE¶ 0.31 0.33 0.93 (0.58, 1.49) 0.748
IgE§ 30.79 37.04 1.07 (0.55, 2.08) 0.848
German 
cockroach
IgG4§ 8.73 21.43 1.98 (1.12, 3.49) 0.020
Total IgE¶ 487.06 983.74 1.75 (1.37, 2.23) <0.001





IgE§ 4481 4316 1.04 (0.86, 1.27) 0.671
SWA
IgG4§ 86035 58160 0.87 (0.37, 2.01) 0.727
IgE§ 4348 4327 0.99 (0.88, 1.14) 0.990
SEA
IgG4§ 90368 93691 1.22 (0.49, 2.99) 0.655
IgE¶ 0.241 1.982 8.30 (5.16, 13.35) <0.001
IgE§ 32.87 73.13 1.33 (0.46, 3.87) 0.584
German 
cockroach
IgG4§ 13.31 19.16 1.26 (0.61, 2.60) 0.516
Total IgE¶ 652.99 934.25 1.70 (1.21, 2.39) 0.003





IgE§ 4520 3969 0.94 (0.83, 1.08) 0.383
SWA
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IgE§ 4389 4005 0.97 (0.85, 1.11) 0.623
SEA
IgG4§ 89975 96456 1.40 (0.72, 2.73) 0.309
IgE¶ 0.10 2.27 30.7 (17.43, 54.25) <0.001
IgE§ 20.14 123.69 8.47 (3.52, 20.40) <0.001House dust mite
IgG4§ 12.99 12.39 1.28 (0.66, 2.51) 0.454
Total IgE¶ 675.19 744.28 1.23 (0.89, 1.70) 0.201
Total IgG4§ 20461.92 14578.97 0.55 (0.28, 1.08) 0.082
Significant associations (p≤0.05) are highlighted in bold.
*reference category
¶Antibody levels detected by ImmunoCAP®. Concentrations are in kU/L. 
§Antibody levels detected by ELISA. Concentrations are in ng/ml. 
‡All geometric mean ratios and 95% confidence intervals adjusted for survey design, age and sex. 
#Geometric mean ratios and 95% confidence intervals for associations between antibody levels and SPT reactivity 
were additionally adjusted for Sm result.
Sm+: positive Kato-Katz and/or PCR test for diagnosis of current infection with S. mansoni; Sm-: negative Kato-Katz 
and PCR test for diagnosis of current infection with S. mansoni; aGMR: adjusted geometric mean ratio; 95% CI: 
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Table 3. Urban survey: associations between antibody (IgE and IgG4) concentrations and current 
S. mansoni infection and skin prick test reactivity 
Antigen Antibody Geometric mean aGMR (95% CI) ‡# p value
Sm- * Sm+
IgE§ 2188 3949 1.75 (1.58, 1.94) <0.001
SWA
IgG4§ 12134 80715 5.93 (3.76, 9.38) <0.001
IgE§ 2434 4660 1.88 (1.63, 2.16) <0.001
SEA
IgG4§ 981 83098 65.9 (41.4, 104.8) <0.001
IgE¶ 0.18 0.25 1.39 (0.65, 3.00) 0.379
IgE§ 16.57 38.20 2.08 (1.05, 4.12) 0.037House dust mite
IgG4§ 19.56 29.02 1.62 (0.99, 2.66) 0.056
IgE¶ 0.18 0.22 1.09 (0.63, 1.88) 0.745
IgE§ 18.04 38.12 1.91 (1.03, 3.53) 0.040
German 
cockroach
IgG4§ 8.78 24.28 2.54 (1.37, 4.71) 0.005
Total IgE¶ 143.21 360.22 2.62 (1.81, 3.79) <0.001





IgE§ 2367 2551 1.08 (0.99, 1.16) 0.057
SWA
IgG4§ 15174 21505 1.41 (0.87, 2.30) 0.152
IgE§ 2645 3187 1.13 (1.03, 1.23) 0.012
SEA
IgG4§ 2131 1171 0.28 (0.12, 0.63) 0.004
IgE¶ 0.13 1.70 13.49 (7.19, 25.32) <0.001
IgE§ 16.39 79.46 4.64 (2.00, 10.78) 0.001
German 
cockroach
IgG4§ 9.08 23.59 3.45 (1.76, 6.77) 0.001
Total IgE¶ 140.72 505.65 4.19 (2.80, 6.28) <0.001





IgE§ 2365 2526 0.99 (0.91, 1.09) 0.915
SWA
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IgE§ 2655 3018 1.02 (0.86, 1.19) 0.835
SEA
IgG4§ 1884 2337 0.55 (0.26, 1.17) 0.113
IgE¶ 0.09 4.86 47.48 (24.1, 93.68) <0.001
IgE§ 10.34 297.85 24.69 (12.9, 47.39) <0.001House dust mite
IgG4§ 20.05 32.33 2.10 (1.53, 2.87) <0.001
Total IgE¶ 141.85 346.98 2.46 (1.65, 3.67) <0.001
Total IgG4§ 12526.67 16210.02 1.26 (0.85, 1.87) 0.233
Significant associations (p≤0.05) are highlighted in bold.
*reference category
¶Antibody levels detected by ImmunoCAP®. Concentrations are in kU/L.
§Antibody levels detected by ELISA. Concentrations are in ng/ml. 
‡All geometric mean ratios and 95% confidence intervals adjusted for survey design, age and sex. 
#Geometric mean ratios and 95% confidence intervals for associations between antibody levels and SPT reactivity 
were additionally adjusted for Sm result.
Sm+: positive Kato-Katz and/or PCR test for diagnosis of current infection with S. mansoni; Sm-: negative Kato-Katz 
and PCR test for diagnosis of current infection with S. mansoni; aGMR: adjusted geometric mean ratio; 95% CI: 
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Table 4. Rural-urban comparison of IgE and IgG4 levels
Antigen Antibody / antibody ratio Geometric mean aGMR (95% CI)‡ p value
Rural* Urban
IgE§ 4452.34 2386.55 0.56 (0.52, 0.61) <0.001
SWA
IgG4§ 82045.65 16091.34 0.24 (0.16, 0.35) <0.001
IgE§ 4340.73 2714.94 0.63 (0.56, 0.71) <0.001
SEA
IgG4§ 90796.70 1957.08 0.03 (0.02, 0.06) <0.001
IgE¶ 0.31 0.19 0.71 (0.50, 0.99) 0.041
IgE§ 35.81 20.65 0.62 (0.42, 0.91) 0.017
IgG4§ 13.97 10.31 0.74 (0.56, 0.98) 0.038
German 
cockroach
IgG4/IgE ratio§ 5.40 5.58 1.00 (0.70, 1.44) 0.984
IgE¶ 0.14 0.19 1.63 (1.03, 2.60) 0.038
IgE§ 24.49 18.91 0.86 (0.60, 1.24) 0.419
IgG4§ 12.89 21.91 1.54 (1.20, 1.96) 0.001
House dust mite
IgG4/IgE ratio§ 11.86 21.44 1.58 (1.12, 2.24) 0.011
Total IgE¶ 682.57 166.23 0.29 (0.22, 0.39) <0.001
Total IgG4§ 19689.40 13254.08 0.71 (0.55, 0.92) 0.011
Total IgG4/total IgE ratio 37.58 98.93 2.54 (1.98, 3.27) <0.001
Total IgE/cockroach IgE ratio¶ 2025.34 895.46 0.45 (0.34, 0.60) <0.001
Total IgE/dust mite IgE ratio¶ 3948.87 898.91 0.23 (0.16, 0.33) <0.001
Significant associations (p≤0.05) are highlighted in bold.
*reference category
¶Antibody levels detected by ImmunoCAP®. Concentrations are in kU/L.
§Antibody levels detected by ELISA. Concentrations are in ng/ml. 
‡All geometric mean ratios and 95% confidence intervals adjusted for survey design, age and sex. 
SWA: Schistosoma adult worm antigen; SEA: Schistosoma egg antigen; aGMR: adjusted geometric mean ratio; 95% 
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FIGURE LEGENDS
Figure 1. Study flowchart.
Figure 2. Associations between antibody ratios and S. mansoni infection and skin prick test 
reactivity. Forest plots show geometric mean ratios (GMRs) and 95% confidence intervals (95% 
CIs) for associations between antibody ratios and (A) current S. mansoni infection and (B, C) 
allergen skin prick test reactivity. Raw antibody responses were skewed, so log10-transformed 
antibody data were used in our linear regression models; we back-transformed the results to obtain 
GMRs and 95% CIs. All GMRs and 95% CIs were adjusted for age and sex, and additionally for 
survey design in the rural and urban surveys. GMRs and 95% CIs for associations with skin prick 
test reactivity were additionally adjusted for S. mansoni infection status. Red colour denotes 
associations where GMR and 95% CI > 1; blue colour denotes associations where GMR and 95% 
CI < 1, and black colour denotes lack of a significant association.
*Antibody levels detected by ELISA. Concentrations are in ng/ml. 
**Antibody levels detected by ImmunoCAP®. Concentrations are in kU/L.
Figure 3. Asthma case-control study: associations between asthma and antibody 
concentrations and ratios. Forest plots show geometric mean ratios (GMRs) and 95% confidence 
intervals (95% CIs) for associations between asthma and antibody concentrations (A) and ratios 
(B). Raw antibody responses were skewed, so log10-transformed antibody data were used in our 
linear regression models; we back-transformed the results to obtain GMRs and 95% CIs. All 
GMRs and 95% CIs were adjusted for age and sex. Red colour denotes associations where GMR 
and 95% CI > 1; blue colour denotes associations where GMR and 95% CI < 1, and black colour 
denotes lack of a significant association.
*Antibody levels detected by ELISA. Concentrations are in ng/ml. 
**Antibody levels detected by ImmunoCAP®. Concentrations are in kU/L.










 RURAL SURVEY 
26 fishing villages in Koome sub-county 
7741 eligible households 
1820 households randomly selected (70 per 
village)  
1419 participating households 
 
3566 participating individuals 
2961 participants: plasma sample stored 
Randomly selected for assessment of at least 
one of total, Schistosoma- or allergen-
specific IgE or IgG4 (n=791) 
 
Data on antibody measurements: 
1. ImmunoCAP® 
Total IgE (n=780; 99%) 
D. pteronyssinus-specific IgE (n=780; 99%) 
B. germanica-specific IgE (n=780; 99%) 
2. ELISA 
Total IgG4 (n=666; 84%) 
D. pteronyssinus-specific IgE (n=768; 97%) 
D. pteronyssinus-specific IgG4 (n=768; 97%) 
B. germanica-specific IgE (n=768; 97%) 
B. germanica-specific IgG4 (n=767; 97%) 
SWA- and SEA-specific IgE (n=755; 95%) 
SWA- and SEA-specific IgG4 (n=766; 97%) 
URBAN SURVEY 
24 sub-wards in Entebbe municipality 
13421 eligible households 
420 households randomly selected for survey 
416 participating households 
1747 participating individuals 
1356 participants: plasma sample stored 
Randomly selected for assessment of at least 
one of total, Schistosoma- or allergen-specific 
IgE or IgG4 (n=1320) 
 
Data on antibody measurements: 
 
 
D. pteronyssinus-specific IgE (n=345; 26%) 
B. germanica-specific IgE (n=345; 26%) 
2. ELISA 
Total IgG4 (n=1121; 85%) 
D. pteronyssinus-specific IgE (n=1316; 99%) 
D. pteronyssinus-specific IgG4 (n=1316; 99%) 
B. germanica-specific IgE (n=1316; 99%) 
B. germanica-specific IgG4 (n=1315; 99%) 
SWA- and SEA-specific IgE (n=1305; 99%) 
SWA- and SEA-specific IgG4 (n=1314; 99%) 
ASTHMA CASE-CONTROL STUDY 
1779 schoolchildren screened for eligibility as 
asthma cases or non-asthmatic controls 
562 cases, 1140 controls enrolled into the study  
557 cases, 1128 controls: plasma sample stored 
Randomly selected for assessment of at least 
one of total, Schistosoma- or allergen-specific 
IgE or IgG4 (n=406) 
 
Data on antibody measurements: 
1. ImmunoCAP® 
Total IgE (n=400; 99%) 
D. pteronyssinus-specific IgE (n=400; 99%) 
B. germanica-specific IgE (n=399; 98%) 
2. ELISA 
Total IgG4 (n=317; 78%) 
D. pteronyssinus-specific IgE (n=384; 95%) 
D. pteronyssinus-specific IgG4 (n=381; 94%) 
B. germanica-specific IgE (n=384; 95%) 
B. germanica-specific IgG4 (n=381; 94%) 
SWA- and SEA-specific IgE (n=382; 94%) 
SWA- and SEA-specific IgG4 (n=384; 95%) 
     
  
   
         
1. ImmunoCAP®*
Total IgE (n=345; 26%)
            
        
               
        
                      
SWA: Schistosoma adult worm antigen; SEA: Schistosoma egg antigen
*Due to cost reasons, ImmunoCAP assay was conducted on 26% of the randomly selected samples in urban survey


